GANINO, LUDOVICA
 Distribuzione geografica
Continente #
AS - Asia 160
NA - Nord America 98
EU - Europa 61
SA - Sud America 7
AF - Africa 3
Totale 329
Nazione #
SG - Singapore 102
US - Stati Uniti d'America 94
IT - Italia 35
HK - Hong Kong 17
CN - Cina 16
DE - Germania 12
VN - Vietnam 10
IN - India 6
BR - Brasile 5
FI - Finlandia 5
GB - Regno Unito 3
NL - Olanda 3
CA - Canada 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
FR - Francia 1
JO - Giordania 1
KH - Cambogia 1
MN - Mongolia 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 329
Città #
Singapore 58
San Jose 26
Hong Kong 17
Ashburn 15
Munich 11
Santa Clara 6
Beijing 5
Bengaluru 5
Hefei 5
Ho Chi Minh City 5
Los Angeles 5
Seattle 5
Turku 5
Dallas 4
Rome 4
Catanzaro 2
Giugliano in Campania 2
Haiphong 2
Hanoi 2
Naples 2
Phoenix 2
Reggio Calabria 2
San Nicola Manfredi 2
San Polo di Torrile 2
Shantou 2
Volla 2
Addis Ababa 1
Amman 1
Asunción 1
Atlanta 1
Barra do Garças 1
Brooklyn 1
Cairo 1
Calgary 1
Campinas 1
Chhibrāmau 1
Chicago 1
Dubai 1
Dundalk 1
Ealing 1
Elk Grove Village 1
Frankfurt am Main 1
Glenolden 1
González Catán 1
Hermosillo 1
Houston 1
Ibiraci 1
Istanbul 1
Juazeiro do Norte 1
Kansas City 1
Kirkland Lake 1
Luanda 1
Mexico City 1
Milan 1
Mānikganj 1
New York 1
Nicosia 1
Phnom Penh 1
Riyadh 1
Salvador 1
Taipei 1
Tulcea 1
Ulan Bator 1
Vallefiorita 1
Totale 236
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 127
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 51
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 43
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 37
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 36
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma (FIRST AUTHOR) 20
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 17
null 11
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 2
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 1
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 1
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance 1
Totale 347
Categoria #
all - tutte 1.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 1 1 0 0 0 0 0 0 4
2024/2025139 2 2 15 25 15 31 23 3 2 0 6 15
2025/2026202 21 16 10 16 36 11 19 24 23 20 6 0
Totale 347